Methylphenidate is often prescribed to children and adolescents for the treatment of ADHD, or attention-deficit/hyperactivity disorder, however, there is no known comprehensive systematic review on the harms and benefits of administering the medication to the young patients. Previous reviews have bias or contain flaws, thus, this research study agrees to use guidelines following the Cochrane Handbook and PRISMA guidelines. Full texts of randomized clinical trials that compared methylphenidate with or without a placebo in the age range of about 3 to 18 years were selected. Pharmaceutical companies were contacted for additional information. Primary outcomes included serious adverse effects and symptoms of ADHD, while secondary outcomes included non-serious adverse effects. No patients were involved in the study. The data was extracted from the trials by reviewers and the authors were contacted for more information. The dose of methylphenidate, design of trials, bias, sex of participants, type of ADHD, and other factors were analyzed in the clinical trials. Concerning quality of evidence, the potential levels of bias associated with the trials evaluated.
Out of 14,431 records, 761 of the publications were included in this review. In the results, a high possibility of bias was found in most trials due to the passion, failure of full coverage blinding, choosy in reporting data, etc. Thus, although many of the outcomes suggest that methylphenidate shows benefits, this cannot be deemed as a true conclusion due to the high risk of bias associated with many trials. Conclusions show that symptoms associated with methylphenidate may be improved and may not cause increase serious adverse effects. However, methylphenidate may result in a high risk of non-serious adverse effects, such as decreased appetite and sleep problems.
I hope to see a future trial that has little risk of bias, which accounts for all the adverse effects that occur as a result. This could help with children and adolescent patients who are currently diagnosed with ADHD and could potentially unveil that they are not receiving the benefits that they believe they are supposed to receive.